Advances in copper metabolism in pathogenesis and treatment of Alzheimer′s disease
CSTR:
Author:
Affiliation:

(Department of Neurology,the Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China)

Clc Number:

Fund Project:

This work was supported by theSpecial Fund of the Fourth Hospital of Harbin Medical University(HYDSYTB2O2306).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Alzheimer′s disease (AD) is a complex neurodegenerative disorder of the central nervous system. Increasing evidence indicates that copper metabolism plays a critical role in its pathogenesis. Copper exerts dual functions in maintaining neuronal activity and redox homeostasis, while its dysregulation may accelerate AD progression by promoting amyloid β-protein (Aβ) aggregation, tau hyperphosphorylation, oxidative stress, and neuroinflammation. In recent years, a newly recognized form of programmed cell death, known as “cuproptosis”, has also been implicated in the neuropathological processes of AD. In this article, we review the physiological mechanisms of copper metabolism and its interactions with Aβ, tau, apolipoprotein E, and other pathogenic factors in AD, with a focus on potential therapeutic strategies targeting copper homeostasis, aiming to provide novel insights into early diagnosis and precise intervention for AD.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:August 09,2025
  • Revised:
  • Adopted:
  • Online: August 05,2026
  • Published:
Article QR Code